TY  - GEN
AU  - Andrikovics,Hajnalka
AU  - Nahajevszky,Sarolta
AU  - Szilvási,Anikó
AU  - Bors,András
AU  - Adám,Emma
AU  - Kozma,András
AU  - Kajtár,Béla
AU  - Barta,Anikó
AU  - Poros,Anna
AU  - Tordai,Attila
TI  - First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts
SN  - 0278-0232
PY  - 2007///1030
KW  - Adult
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzamides
KW  - Chromosome Breakage
KW  - Female
KW  - Fusion Proteins, bcr-abl
KW  - metabolism
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Pyrimidines
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hon.822
ER  -